ProfileGDS4718 / 205232_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 72% 67% 52% 69% 72% 56% 56% 69% 72% 73% 75% 70% 65% 58% 57% 69% 76% 59% 62% 45% 66% 69% 77% 69% 67% 58% 74% 55% 74% 57% 65% 51% 67% 79% 57% 54% 58% 63% 70% 49% 79% 64% 55% 49% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.0540872
GSM549102patient 115, normal, homogenized [OPG study]6.634167
GSM549104patient 119, normal, homogenized [OPG study]5.6241352
GSM549108patient 138, normal, homogenized [OPG study]6.7291569
GSM549119patient 077, normal, homogenized [OPG study]6.9860472
GSM549133patient 032, cancer, homogenized [OPG study]5.8255456
GSM549139patient 042, cancer, homogenized [OPG study]5.8441956
GSM549099patient 107, normal, homogenized [OPG study]6.7146369
GSM549109patient 139, normal, homogenized [OPG study]7.0580472
GSM549110patient 046, normal, homogenized [OPG study]7.1322573
GSM549114patient 063, normal, homogenized [OPG study]7.3377875
GSM549122patient 082, normal, homogenized [OPG study]6.8729570
GSM549134patient 033, cancer, homogenized [OPG study]6.4493665
GSM549136patient 036, cancer, homogenized [OPG study]5.9543858
GSM549140patient 044, cancer, homogenized [OPG study]5.9238257
GSM549111patient 047, normal, homogenized [OPG study]6.7893769
GSM549113patient 057, normal, homogenized [OPG study]7.4567576
GSM549132patient 031, cancer, homogenized [OPG study]6.0186759
GSM549137patient 038, cancer, homogenized [OPG study]6.2386362
GSM549142patient 047, cancer, homogenized [OPG study]5.3722345
GSM549100patient 110, normal, homogenized [OPG study]6.5089466
GSM549107patient 135, normal, homogenized [OPG study]6.7606369
GSM549115patient 068, normal, homogenized [OPG study]7.6237777
GSM549116patient 072, normal, homogenized [OPG study]6.835169
GSM549120patient 078, normal, homogenized [OPG study]6.6452667
GSM549131patient 030, cancer, homogenized [OPG study]5.9925958
GSM549118patient 074, normal, homogenized [OPG study]7.2299574
GSM549129patient 027, cancer, homogenized [OPG study]5.8004755
GSM549123patient 088, normal, homogenized [OPG study]7.2245474
GSM549124patient 006, cancer, homogenized [OPG study]5.9641457
GSM549126patient 015, cancer, homogenized [OPG study]6.4969565
GSM549128patient 025, cancer, homogenized [OPG study]5.55851
GSM549103patient 117, normal, homogenized [OPG study]6.6297967
GSM549117patient 073, normal, homogenized [OPG study]7.8065379
GSM549138patient 041, cancer, homogenized [OPG study]5.9318957
GSM549141patient 045, cancer, homogenized [OPG study]5.6899854
GSM549130patient 028, cancer, homogenized [OPG study]6.0069258
GSM549101patient 111, normal, homogenized [OPG study]6.3246863
GSM549105patient 128, normal, homogenized [OPG study]6.8583570
GSM549106patient 134, normal, homogenized [OPG study]5.4277349
GSM549112patient 048, normal, homogenized [OPG study]7.7686579
GSM549125patient 011, cancer, homogenized [OPG study]6.430864
GSM549127patient 024, cancer, homogenized [OPG study]5.8154355
GSM549135patient 035, cancer, homogenized [OPG study]5.4263149